FIELD: medicine, pediatry. SUBSTANCE: method involves administration in child thiotriazoline in a dose 0.05-0.1 g, 2 times per a day for 12-16 days in combination with conventional complex therapy. Thiotriazoline shows anti-ischemic, membrane-stabilizing, antioxidant and immunomodulating activities. EFFECT: enhanced effectiveness of treatment of children with renal dysplasia, decreased time of treatment. 2 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRESERVATIVE SOLUTION FOR TRANSPLANTS | 1997 |
|
RU2140152C1 |
| METHOD OF TREATING OCCLUDING INJURIES OF CORNEAL AND OPTIC-NERVE VESSELS | 1995 |
|
RU2122384C1 |
| METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| 6-NITRO-3H-QUINAZOLON-4-YL-3-ACETIC ACID SODIUM SALT HAVING ANTIOXIDANT AND ISCHEMIC ACTIVITIES | 1997 |
|
RU2146249C1 |
| 6-NITRO-3H-QUINAZOLONE-4-YL-3-ACETIC ACID MONOETHANOLAMMONIUM SALT SHOWING ANTIOXIDANT AND ANTI-ISCHEMIC ACTIVITIES | 1997 |
|
RU2145960C1 |
| METHOD FOR PREVENTING SUBEPITHELIAL FIBROPLASIA FROM OCCURRING AFTER PHOTOREFRACTION KERATECTOMY | 2003 |
|
RU2272621C2 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| COMBINED ANTITUBERCULOUS DRUGS | 2013 |
|
RU2545731C1 |
